Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

一项针对接受原发性乳腺癌化疗的绝经前妇女，评估利塞膦酸钠预防骨质流失的III期随机、安慰剂对照、双盲试验